Overview

Dose-escalating Safety Study in Subjects on Stable Statin Therapy

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the safety of varying doses of ISIS 301012 in subjects on Stable statin therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Kastle Therapeutics, LLC
Collaborator:
Ionis Pharmaceuticals, Inc.
Treatments:
Mipomersen